Author: healthadmin
Medicare Advantage now covers more than half of beneficiaries, but federal enforcement, mostly with relatively small penalties, may not be enough to ensure accountability across the rapidly expanding system, a new study finds. Study: Federal Enforcement Action Against Medicare Advantage Plans. Image credit: dailyplus/Shutterstock.com Recent research published in JAMA Internal Medicine Highlights opportunities to strengthen federal enforcement of private Medicare plans. The researchers analyzed enforcement actions in more than 1,100 contracts over 10 years and found that penalties vary from year to year and remain relatively modest. Approximately 42% of contracts Cited at least once, Questions have been raised about…
While GLP-1 drugs are revolutionizing obesity treatment, new research reveals a surprising reality. People can face stigma whether they lose weight, gain it back, or don’t lose weight at all. Research: An experimental study of the use and discontinuation of GLP-1 receptor agonists to blame for weight loss and recovery. Image credit: KaterynaBorodina/Shutterstock.com In a recent study published in International Journal of ObesityA group of researchers investigated whether people experience stigma after losing or regaining weight after using and discontinuing glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs. Public attitudes toward GLP-1 weight loss remain divided Weight loss drugs such as GLP-1RA…
WASHINGTON (AP) – The Trump administration will soon propose loosening Biden-era limits on “permanent chemicals” in drinking water, deferring stricter standards for two common types and eliminating limits on some rarer forms, according to Environmental Protection Agency officials.The proposal begins the first-ever formal process to roll back parts. Restrictions on PFAS in drinking water It was finalized during former President Joe Biden’s administration. Authorities at the time found they increased the risk of cardiovascular disease, certain cancers, and low birth weight babies.Jessica Cramer, director of the Environmental Protection Agency’s Office of Water, said Thursday at a conference in Washington, D.C.,…
Hims & Hers has launched an artificial intelligence agent embedded in its platform to help interpret biomarker test results and provide users with personalized insights about their health. The company launched a direct-to-consumer clinical testing program for health biomarker testing in November. The new agent AI, Labs AI, is available to some customers in beta testing and will be rolled out to all Labs customers over time, the company announced Thursday. As part of its strategy to expand into prevention and health screening, Hims & Hers’ Labs is offering access to 130 biomarker tests across 10 health areas including heart…
Researchers led by Helmholtz Munich’s metabolic expert Professor Timo D. Müller have developed a new strategy to treat obesity and type 2 diabetes. Their approach uses specially designed hybrid molecules that utilize the well-known GLP-1/GIP signaling pathway as a type of entry point into cells. Once in the body, it delivers additional metabolic compounds directly to where they are needed. In clinical tests, mice treated with the compound ate less, lost more weight, and showed better blood sugar control than mice treated with the standard comparison treatment. The results of this study were published in a journal as a preclinical…
Cranberry juice may help extend the life of a major urinary tract infection antibiotic by reprogramming the way bacteria absorb fosfomycin and develop resistance. Study: Cranberry juice enhances the susceptibility of uropathogenic Escherichia coli (UPEC) strains to fosfomycin and reduces the development of spontaneous resistance. Image credit: New Africa/Shutterstock.com In a recent study published in Applied and environmental microbiologyResearchers have shown that cranberry juice (CJ) enhances the antibacterial activity of fosfomycin (FOS) and reduces the development of resistance in uropathogenic diseases. Escherichia coli (UPEC). Rising UTI resistance accelerates search for alternative treatments UPEC is the main causative agent of urinary…
Insulet has always been a strong leader in the medical technology industry when it comes to marketing strategy. And this diabetes equipment maker has no intention of resting on its laurels. The company, which sells Omnipod, a wearable insulin patch, told investors in a May 6 statement during its first-quarter financial report that it is looking to increase marketing and awareness in the U.S. to grow sales. Omnipod’s exposure on national television platforms and targeted brand campaigns “has resulted in measurable increases in patient engagement and script reinvigoration,” the company said. “Our brand investments also deliver unique commercial value. We…
Explore how telemedicine innovations, wearable tech, and AI diagnostics are transforming healthcare by addressing staffing shortages, rising costs, and access barriers in 2026.
Lithium salts have shown promise in treating Alzheimer’s disease by preventing certain proteins in the brain from clumping together, but how they affect cells on a broader scale is largely unknown. Recent research published in journals Biomedicine and pharmacotherapy The researchers found that lithium chloride alters multiple cellular pathways beyond its primary targets, altering the activity of various enzymes and structural proteins associated with dementia. These results suggest that changing the type of lithium used in treatment may improve outcomes for patients experiencing memory loss and cognitive decline. Alzheimer’s disease is the most common form of dementia and is characterized…
new research in psycho journal We introduce and examine a psychological concept called aversophobia, defined as an intense fear of losing honor or being labeled shameless. Aversive phobias are culturally specific in their origins and manifest through intrusive thoughts, hypervigilance, emotional agitation, and compulsive obedience to social norms tied to moral reputation and family dignity. Investigators developed the Amophobia Scale (AtiPhoS), a 15-item tool designed to measure this specific fear across four dimensions: fear of being considered shameless, fear of violating social norms, fear of public judgment, and fear of losing self-esteem and honor. Researchers found that aversive phobia was…